← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Lanreotide currently has availability issues reported in 2 European registers: Austria, Italy.
Shortage ATC — · also listed as: LANREOTID ACETAT · LANREOTIDE · data refreshed 5 September 2026
As of 5 September 2026, 2 of the 9 tracked registers list current availability issues for Lanreotide, covering 5 affected product presentations. The longest-running open report was filed in Italy on 2023-09-28 and has now been open for about 36 months. Where agencies state a cause, manufacturing problems lead with 2 of the 2 stated-cause reports. The furthest expected-resolution date currently on file is 2027-03-31; the earliest is 2026-12-31. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇦🇹 Austria | Shortage Mytolac 120 mg Injektionslösung in einer Fertigspritze + 2 more productsMytolac 60 mg Injektionslösung in einer Fertigspritze Mytolac 90 mg Injektionslösung in einer Fertigspritze | 2025-05-26 | — | — | register ↗ |
| 🇮🇹 Italy | Shortage MYRELEZ® + 1 more productsMYRELEZ® | 2023-09-28 | 2027-03-31 | Problemi produttivi Alternatives: AIFA: import of a foreign equivalent can be authorised. | register ↗ |
Every individual register entry for Lanreotide in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇦🇹 AT | Mytolac 120 mg Injektionslösung in einer Fertigspritze | Shortage | 2025-05-26 | — | |
| 🇦🇹 AT | Mytolac 60 mg Injektionslösung in einer Fertigspritze | Shortage | 2025-05-26 | — | |
| 🇦🇹 AT | Mytolac 90 mg Injektionslösung in einer Fertigspritze | Shortage | 2025-05-26 | — | |
| 🇮🇹 IT | MYRELEZ® | Shortage | 2023-11-29 | 2026-12-31 | Problemi produttivi |
| 🇮🇹 IT | MYRELEZ® | Shortage | 2023-09-28 | 2027-03-31 | Problemi produttivi |
Yes. As of 5 September 2026, availability issues are reported in: Austria, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-12-31 to 2027-03-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Lanreotide: BASG (Austria), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Lanreotide — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/lanreotide/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Lanreotide availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/lanreotide/">Lanreotide shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>